Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TELA - TELA Bio, Inc.

IEX Last Trade
2.91
0.090   3.093%

Share volume: 1,047
Last Updated: Thu 26 Dec 2024 08:26:07 PM CET

PREVIOUS CLOSE
CHG
CHG%
$2.82
0.09
3.19%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.39%
1 Month
-5.61%
3 Months
9.16%
6 Months
-44.89%
1 Year
-56.13%
2 Year
-74.58%
Key data
Stock price
$2.91
P/E Ratio 
0.00
DAY RANGE
$2.81 - $2.91
EPS 
$0.00
52 WEEK RANGE
$2.44 - $7.84
52 WEEK CHANGE
-$54.68
MARKET CAP 
71.670 M
YIELD 
N/A
SHARES OUTSTANDING 
24.714 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$334,634
AVERAGE 30 VOLUME 
$204,798
Company detail
CEO: Antony Koblish
Region: US
Website: telabio.com
Employees: 120
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

TELA Bio, Inc. focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company markets its products through a single direct sales force, principally in the United States.

Recent news